XML 13 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Private Placement [Member]
Series Seed [Member]
Series A [Member]
Series B [Member]
Series C [Member]
Common Stock
Common Stock
Private Placement [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Private Placement [Member]
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance, Temporary equity at Dec. 31, 2024     $ 435 $ 6,179 $ 580 $ 107,065            
Beginning Balance at Dec. 31, 2024 $ (94,554)           $ 1   $ 9,657   $ (104,323) $ 111
Beginning balance, Temporary equity, shares at Dec. 31, 2024     295,467 3,655,374 301,119 73,820,346            
Beginning Balance, shares at Dec. 31, 2024             251,655          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 634               634      
Unrealized gain (loss) on marketable securities $ (111)                     (111)
Shares issued upon exercise of option, shares 0                      
Net Income (Loss) $ (5,306)                   (5,306)  
Ending Balance at Mar. 31, 2025 (99,337)           $ 1   10,291   (109,629)  
Ending balance, Temporary equity at Mar. 31, 2025     $ 435 $ 6,179 $ 580 $ 107,065            
Ending Balance, shares at Mar. 31, 2025             251,655          
Ending balance, Temporary equity, shares at Mar. 31, 2025     295,467 3,655,374 301,119 73,820,346            
Beginning Balance at Dec. 31, 2025 301,310           $ 3   430,667   (129,528) 168
Beginning Balance, shares at Dec. 31, 2025             25,299,372          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 2,566               2,566      
Unrealized gain (loss) on marketable securities 40                     40
Shares issued upon exercise of options and warrants $ 29               29      
Shares issued upon exercise of option, shares 1,000           68,884          
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs   $ 93,802               $ 93,802    
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs, shares               3,306,571        
Net Income (Loss) $ (19,054)                   (19,054)  
Ending Balance at Mar. 31, 2026 $ 378,693           $ 3   $ 527,064   $ (148,582) $ 208
Ending Balance, shares at Mar. 31, 2026             28,674,827